Diabetes Mellitus News and Research

RSS
Diabetes mellitus is a severe and debilitating chronic disease that develops in nearly 5 percent of the world’s population. People with this disease have a shortage of insulin or a reduced ability to use insulin, the hormone regulating blood glucose levels, which is normally produced by the pancreas. In the United States alone, an estimated 18 million people have diabetes, and each year about 1 million Americans are diagnosed with the disease. It is the sixth leading cause of death in the US and is responsible for over 200,000 deaths a year. Insulin-dependent (type I) diabetes accounts for around 10% of diabetics. For those patients, suffering from an inability of their pancreas to produce insulin, the only practical treatment possible is regular insulin replacement by multiple daily injections. Transplantation of a pancreas or pancreatic tissue would be beneficial to millions of such patients in that it would restore their normal ability to produce self insulin. Transplantation of human pancreas or pancreatic islets is a practiced and time-honored such therapeutic approach, but is extremely limited by the severe shortage of human donor organs. Tissera's R&D efforts in this domain are directed towards the development of a universally available and reliable source of animal fetal donor pancreatic precursor tissue, suitable for transplantation and eventual normal structural and functional growth in human diabetics.
Heart attacks more likely to be fatal in women and rates are rising

Heart attacks more likely to be fatal in women and rates are rising

Patients with diabetes mellitus have high risk of stable ischemic heart disease

Patients with diabetes mellitus have high risk of stable ischemic heart disease

Large-scale clinical trial begins to study liver transplantation between people with HIV

Large-scale clinical trial begins to study liver transplantation between people with HIV

Study investigates the role of estrogen in controlling glucose homeostasis

Study investigates the role of estrogen in controlling glucose homeostasis

Researchers discover mechanism on how body's antimicrobial shield regulates microbiome

Researchers discover mechanism on how body's antimicrobial shield regulates microbiome

Insulin in a pill from MIT researchers

Insulin in a pill from MIT researchers

Researchers describe first case of patient affected by dysfunctions in SLC28 gene family

Researchers describe first case of patient affected by dysfunctions in SLC28 gene family

Vitamin D may lower glucose levels and reduce risk of developing type 2 diabetes

Vitamin D may lower glucose levels and reduce risk of developing type 2 diabetes

New analytic method can precisely detect viral infections using immune responses

New analytic method can precisely detect viral infections using immune responses

Link between glycemic control and family support among Nigerians with type 2 diabetes mellitus

Link between glycemic control and family support among Nigerians with type 2 diabetes mellitus

Study: Brain connectivity network in T1D patients is different from healthy people

Study: Brain connectivity network in T1D patients is different from healthy people

Eisai enters into agreement with Eurofarma for its anti-obesity agent lorcaserin

Eisai enters into agreement with Eurofarma for its anti-obesity agent lorcaserin

Study: One in five young adults in India has hypertension

Study: One in five young adults in India has hypertension

Gut protein mutations protect against spikes in blood glucose levels

Gut protein mutations protect against spikes in blood glucose levels

Non-coding genetic variant plays key role in endothelial function and disease incidence

Non-coding genetic variant plays key role in endothelial function and disease incidence

Mylan and Biocon launch new insulin glargine biosimilar in the UK

Mylan and Biocon launch new insulin glargine biosimilar in the UK

AstraZeneca to present Phase III CVOT DECLARE-TIMI 58 results at AHA Scientific Sessions

AstraZeneca to present Phase III CVOT DECLARE-TIMI 58 results at AHA Scientific Sessions

Study reveals safety, efficacy of brexpiprazole for schizophrenia patients with severe psychotic symptoms

Study reveals safety, efficacy of brexpiprazole for schizophrenia patients with severe psychotic symptoms

High-impact clinical trial results could affect kidney-related medical care

High-impact clinical trial results could affect kidney-related medical care

Merck presents MK-1454 Phase 1 data for treatment of advanced solid tumors or lymphomas

Merck presents MK-1454 Phase 1 data for treatment of advanced solid tumors or lymphomas